Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 107 (2) , 756-763
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritisInflammopharmacology, 2017
- Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control studyBMJ, 2016
- The role of 20-HETE in cardiovascular diseases and its risk factorsProstaglandins & Other Lipid Mediators, 2016
- Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal ComplicationsJournal of Pharmacy & Pharmaceutical Sciences, 2013
- Drug Disease Interactions: Role of Inflammatory Mediators in Pain and Variability in Analgesic Drug ResponseJournal of Pharmacy & Pharmaceutical Sciences, 2007
- Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat heartsJournal of Molecular and Cellular Cardiology, 2007
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005
- THERAPEUTIC RELEVANCE OF ALTERED CYTOKINE EXPRESSIONCytokine, 2001
- A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9Circulation Research, 2000
- Prostaglandins, thromboxanes, and leukotrienes in inflammationThe American Journal of Medicine, 1986